Patents by Inventor Ricardo Carl Elciario Dolmetsch

Ricardo Carl Elciario Dolmetsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol use
    Patent number: 12201612
    Abstract: The invention relates to the use of mavoglurant, or a pharmaceutically acceptable salt thereof: in the reduction of alcohol use by an alcohol use disorder patient; in preventing relapse into alcohol use by an alcohol use disorder patient; in the promotion of alcohol abstinence by an alcohol use disorder patient; in the treatment of the symptoms of depression or anxiety associated with alcohol use disorder.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: January 21, 2025
    Assignee: NOVARTIS AG
    Inventors: Ricardo Carl Elciario Dolmetsch, Fabrizio Gasparini, Baltazar Gomez-Mancilla, Donald Johns
  • Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use
    Patent number: 11878001
    Abstract: The invention relates to the use of mavoglurant, or a pharmaceutically acceptable salt thereof: in the reduction of cocaine use by a cocaine use disorder patient; in preventing relapse into cocaine use by a cocaine use disorder patient; in the promotion of cocaine abstinence by a cocaine use disorder patient; in in the treatment of the symptoms of depression or anxiety associated with cocaine use disorder.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: January 23, 2024
    Assignee: NOVARTIS AG
    Inventors: Ricardo Carl Elciario Dolmetsch, Fabrizio Gasparini, Baltazar Gomez-Mancilla, Donald Johns
  • USE OF MAVOGLURANT IN THE REDUCTION OF COCAINE USE OR IN PREVENTING RELAPSE INTO COCAINE USE
    Publication number: 20210093609
    Abstract: The invention relates to the use of mavoglurant, or a pharmaceutically acceptable salt thereof: in the reduction of cocaine use by a cocaine use disorder patient; in preventing relapse into cocaine use by a cocaine use disorder patient; in the promotion of cocaine abstinence by a cocaine use disorder patient; in in the treatment of the symptoms of depression or anxiety associated with cocaine use disorder.
    Type: Application
    Filed: July 30, 2018
    Publication date: April 1, 2021
    Inventors: Ricardo Carl Elciario Dolmetsch, Fabrizio Gasparini, Baltazar Gomez-Mancilla, Donald Johns
  • USE OF MAVOGLURANT IN THE REDUCTION OF ALCOHOL USE OR IN PREVENTING RELAPSE INTO ALCOHOL USE
    Publication number: 20200237721
    Abstract: The invention relates to the use of mavoglurant, or a pharmaceutically acceptable salt thereof: in the reduction of alcohol use by an alcohol use disorder patient; in preventing relapse into alcohol use by an alcohol use disorder patient; in the promotion of alcohol abstinence by an alcohol use disorder patient; in the treatment of the symptoms of depression or anxiety associated with alcohol use disorder.
    Type: Application
    Filed: July 30, 2018
    Publication date: July 30, 2020
    Inventors: Ricardo Carl Elciario Dolmetsch, Fabrizio Gasparini, Baltazar Gomez-Mancilla, Donald Johns